Public Company News
Noah Holdings Limited Files FY2021 Annual Report On Form 20-F
SHANGHAI, April 6, 2022 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH), a leading and pioneer wealth management service provider inChina offering comprehensive one-stop advisory services on global investment and asset allocation primarily for high net worth investors...
2022-04-06 21:27
4478
China Jo-Jo Drugstores, Inc. Announces 1-for-12 Reverse Stock Split
HANGZHOU, China, April 6, 2022 /PRNewswire/ – China Jo-Jo Drugstores, Inc. (" Jo-Jo Drugstores" or the "Company") (Nasdaq: CJJD), a Cayman Islands company, reported that it expects to implement a 1-for-12 reverse stock split on its ordinary shares effectiveThursday, April 7, 2022, with trading to ...
2022-04-06 21:15
4085
Caravelle Group Co., Ltd, an Ocean Technology and Shipping Company, to Become Publicly Traded via Merger with Pacifico Acquisition Corp.
* Caravelle Group Co., Ltd ("Caravelle") is an ocean technology company providing international shipping services and carbon-neutral solutions for wood desiccation. * Caravelle has developed and commercialized its CO-Tech solution, a novel approach toward shipping time, space, and the repurpo...
2022-04-06 21:00
4025
ZEISS to Unveil Clinical Insights Supporting the Value of New Data-Driven Digital Workflow Solutions and Software Applications
Advancing ophthalmic care through integrated clinical workflow solutions: * Efficiency in the cataract workflow * Can help increase treatment outcome predictability in the corneal refractive workflow * Machine learning and artificial intelligence in the retina clinic JENA, Germany and DUBLI...
2022-04-06 21:00
2865
Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark
* Test detects 21 targets for 19 respiratory viruses in single tube, including COVID-19 and flu * Assay result of Seegene's decades-long know-how, applies DPO∙TOCE∙MuDT technologies * "Optimal solution for safe return to normalcy as distancing restrictions eased" SEOUL, South Korea, April 6...
2022-04-06 20:08
2876
Antengene's Pivotal "MARCH" Study to Evaluate Selinexor (ATG-010) in Relapsed or Refractory Multiple Myeloma Published in BMC Medicine
- Results showed an overall response rate (ORR) of 29.3% for all treated patients. - Consistent responses across all risk groups, including patients who received prior "triple-class" and CAR-T therapies or having cytogenetic abnormalities. - Selinexor is on track for a Q2:22 launch in China. SHAN...
2022-04-06 20:03
4442
Volition appoints Sharon Ballesteros as U.S. Head of Quality and Development Process
AUSTIN, Texas, April 6, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced the appointment ofSharon Ballesteros as U.S Head of Quality and Development Process. Sharon has over 20 years of experience within the in vitro d...
2022-04-06 20:00
3819
Quantum Solutions and FOMM to Manufacture First Electric Vehicle for the Japan Market Since Establishing Joint Venture
HONG KONG, April 6, 2022 /PRNewswire/ -- Quantum Solutions (Quantum), the only independent electric vehicle (EV) company listed inJapan, announced that a major shareholder has granted a400-million-yen loan to begin production of its first EV model with its joint-venture partner. This is a crucia...
2022-04-06 17:34
4271
Ascletis Announces China IND Approval of Its Second FASN Inhibitor ASC60 for Treatment of Advanced Solid Tumors
HANGZHOU, China and SHAOXING, China, April 6, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that the Investigational New Drug (IND) application of its second fatty acid synthase (FASN) inhibitor ASC60 for treatment of advanced solid tumors has been approved by China ...
2022-04-06 17:10
4798
Jianpu Technology Inc. to Report Second Six Months and Fiscal Year 2021 Financial Results on Tuesday, April 12, 2022
BEIJING, April 6, 2022 /PRNewswire/ -- Jianpu Technology Inc. ("Jianpu," or the "Company") (NYSE: JT), a leading independent open platform for discovery and recommendation of financial products inChina, today announced that it will report its second six months and fiscal year 2021 unaudited finan...
2022-04-06 17:00
3563
Harbour BioMed Announces Poster Presentation on the Novel Bispecific Antibody PD-L1xCD40 at Upcoming American Association for Cancer Research (AACR) Annual Meeting
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, April 6, 2022 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics, today announced that the poster presenta...
2022-04-06 15:04
3122
Pintec Empowers Wagepay to Upgrade Digital Credit Services
MELBOURNE, Australia, April 6, 2022 /PRNewswire/ -- Pintec Technology Holdings Limited ("Pintec"; NASDAQ: PT), a leading provider of financial technology solutions, today announced that its partner Wagepay Pty. Ltd. (Wagepay), an Australian Pay-on-Demand service provider, has recently launched it...
2022-04-06 13:11
5875
PSMA-PET Imaging to be Funded through Medicare in Australia from July 2022
MELBOURNE, Australia, April 6, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) welcomes the listing of prostate-specific membrane antigen (PSMA) positron emission tomography (PET) (PSMA-PET) imaging for patients with prostate cancer on the Medicare Benefits Sche...
2022-04-06 12:47
3891
Innovent Announces the Approval of Pemazyre® (pemigatinib) by the NMPA for the Treatment of Adults with Locally Advanced or Metastatic Cholangiocarcinoma with A FGFR2 Fusion or Rearrangement As Confirmed By A Validated Diagnostic Test That Have Progressed After at Least One Prior Line of Systemic Therapy
SAN FRANCISCO and SUZHOU, China, April 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...
2022-04-06 12:43
4396
CIMC generates $25.7 billion in operating revenue, marking the fastest y-o-y growth in nearly 10 years
SHENZHEN, China, April 5, 2022 /PRNewswire/ -- Chinese leading logistics and energy equipment supplier China International Marine Containers (Group) Ltd posted approximately163.7 billion yuan ($25.7 billion) in operating revenue in 2021, a 74-percent growth year-on-year, marking the first time fo...
2022-04-06 10:11
4231
Black Desert SEA Welcomes New Mountain of Eternal Winter Expansion and Drakania Class
SEOUL, South Korea, April 6, 2022 /PRNewswire/ -- Pearl Abyss announced today that the new Mountain of Eternal Winter expansion and Drakania class are now available in Black Desert SEA. Starting today, Adventurers can explore breathtaking snow-capped peaks with the descendant of a legendar...
2022-04-06 10:00
3499
Kintor Pharma's Proxalutamide Demonstrated Reduction in Hospitalization/Mortality for Patients with Mild to Moderate COVID-19 in Phase III MRCT Study
* Proxalutamide demonstrates a significant reduction in hospitalization/death rate with a protection rate reaching 100% for patients treated more than seven days (p <0.02). * Proxalutamide reduced risk of hospitalization or death especially in those with high-risk factors. * Proxalutamid...
2022-04-06 09:22
2198
Leclanché selected to provide 10 MWh advanced battery system for Scandlines' "PR24" zero-emission freight ferry
* World's largest hybrid ferry will run on a Leclanché liquid-cooled, lithium-ion battery system, produced in Leclanché's European factories * Scandlines PR24 will connect Puttgarden, on the German island of Fehmarn, and Rødby port on Lolland,Denmark – a 18.5 km distance * Leclanché Marine R...
2022-04-06 08:30
3735
Everest Medicines Announces that Topline Results from Chinese Subpopulation Consistent With Global Phase 3 NefIgArd Study Part A Analysis
SHANGHAI, April 6, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, announced today t...
2022-04-06 08:00
3500
IAS Continues Reporting Innovation by Enhancing IAS Signal with Unified View and Attention Metrics
SINGAPORE, April 6, 2022 /PRNewswire/ -- Integral Ad Science (Nasdaq: IAS), a global leader in digital media quality, announced new reporting enhancements that provide advertisers with a unified view of their global campaigns. Clients will now be able to analyze data by custom filters created aut...
2022-04-06 08:00
2873
Week's Top Stories
Most Reposted
Vietnam: TotalEnergies ENEOS Commissions 28 MWp Rooftop Solar Project at Samsung Electronics HCMC CE Complex
[Picked up by 307 media titles]
2026-07-03 17:10
InfoComm Asia 2026 - Asia's Super Connector for Professional AV - Takes Place Next Week in Bangkok
[Picked up by 295 media titles]
2026-07-07 09:00
PropertyGuru Group's 2025 Sustainability Report Reinforces its Commitment to More Resilient and Inclusive Urban Futures Across Southeast Asia
[Picked up by 288 media titles]
2026-07-08 12:09
Gene Solutions' SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight
[Picked up by 283 media titles]
2026-07-07 06:00
NCS launches enterprise AI platforms and products; deepens partnerships to accelerate AI-driven business transformation
[Picked up by 283 media titles]
2026-07-09 08:00Most Read
JINRO, the World's No. 1 Soju Brand, Partners with V of BTS
2026-07-03 08:00
20759
Vietnam: TotalEnergies ENEOS Commissions 28 MWp Rooftop Solar Project at Samsung Electronics HCMC CE Complex
2026-07-03 17:10
8406
GROWNSY's Baby Food Maker Named "Baby Food Maker Product of the Year" in the 2026 Baby Innovation Awards
2026-07-03 21:00
7626
